Abiopharma

New Form 4 - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086173 Size: 5 KB

New Form 4 - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086171 Size: 5 KB

New Form 8-K - INTENSITY THERAPEUTICS, INC. Filed: 2025-06-13 AccNo: 0001628280-25-031311 Size: 869 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086172 Size: 5 KB

New Form 4 - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086167 Size: 5 KB

New Form 4 - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086174 Size: 5 KB

New Form 144 - PUMA BIOTECHNOLOGY, INC. Filed: 2025-06-13 AccNo: 0001959173-25-004069 Size: 4 KB

New Form 4 - Trevi Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086165 Size: 5 KB

New Form S-3 - Lexeo Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140744 Size: 340 KB

New Form 4 - Ginkgo Bioworks Holdings, Inc. Filed: 2025-06-13 AccNo: 0001127602-25-017475 Size: 9 KB

New Form 144 - Enliven Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001974158-25-000040 Size: 6 KB

New Form 4 - Adicet Bio, Inc. Filed: 2025-06-13 AccNo: 0000950170-25-086163 Size: 7 KB

New Form 8-K - CytomX Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140739 Size: 326 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and …

New Form 144 - PUMA BIOTECHNOLOGY, INC. Filed: 2025-06-13 AccNo: 0001959173-25-004068 Size: 4 KB

New Form 15-12G - PaxMedica, Inc. Filed: 2025-06-13 AccNo: 0001641172-25-015071 Size: 13 KB